CHPT1 Antibodies

Santa Cruz Biotechnology features a diverse variety of CHPT1 monoclonal antibodies for various research applications. CHPT1 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CHPT1, or choline phosphotransferase 1, plays a crucial role in the synthesis of phosphatidylcholine, a key component of cell membranes. CHPT1 is essential for maintaining cellular integrity and function, and its dysregulation has been implicated in various diseases, including cancer and neurodegenerative disorders. Understanding CHPT1's role in cellular processes can provide insights into potential therapeutic targets and disease mechanisms. Researchers worldwide utilize CHPT1 monoclonal antibodies to advance their understanding of membrane biology and cellular signaling pathways. CHPT1 monoclonal antibodies enable detailed investigation of phosphatidylcholine synthesis and its impact on cell membrane dynamics. Santa Cruz Biotechnology monoclonal antibodies support researchers in their mission to uncover new therapeutic strategies and advance scientific knowledge in cell biology and disease research.